Search

everythinglearnresearchcommunity

for

Search:↓

Certain fats in the blood are linked to an increased risk of male pattern baldness.

Two women with darker skin had both frontal hair thinning and skin discoloration.

FAPD and possibly CCCA may be AGA subtypes, and treatments combining antiandrogens, hair growth agents, hair transplants, and anti-inflammatories could be effective.

A man was diagnosed with a rare form of lupus after showing unique skin symptoms that responded well to treatment.

Female pattern baldness may indicate a higher risk of coronary artery disease.

Calcium hydroxylapatite can be successfully integrated into healing skin and stimulates collagen.

People with alopecia areata have a higher risk of stroke.

Simvastatin/ezetimibe may help treat new cases of alopecia areata but not long-term cases.

Treatment improved scalp conditions and hair loss with no recurrence after 1 year.

Atorvastatin may cause hair loss in some people.

Granulomatous Alopecia Areata is rare and may be caused by hair antigens or follicle destruction.

A woman's rare hair loss condition improved on its own, suggesting this type might recover like common cases.

Lipocartilage is a new type of tissue that affects hair growth and cartilage regeneration.

Genetic testing for hairless gene mutations is crucial to correctly diagnose and treat atrichia with papular lesions.

Phosphatide distribution in mouse skin remains consistent in both normal and cancerous growths.

Androgenetic alopecia may be linked to certain lipid levels, but its connection to coronary artery disease is unclear.

Male pattern baldness is not a risk factor for heart disease based on cholesterol levels alone.

Calcium fatty acid deposits found in human hair can change its appearance and feel.

Eczema patients have a lower skin lipid to protein ratio, older and longer-staying hospital patients are more likely to get pressure ulcers, hair loss in AGA is linked to muscle degeneration, vitamin D deficiency is common in alopecia areata and linked to its severity, standard liver tests don't effectively detect fibrosis in psoriasis patients on methotrexate, and bullous pemphigoid patients have a higher death risk but combination therapy may reduce it.

Cicatricial alopecia, a permanent hair loss condition, is mainly caused by damage to specific hair follicle stem cells and abnormal immune responses, with gene regulator PPAR-y and lipid metabolism disorders playing significant roles.

The conclusion is that fat grafting is safe and effective but carries risks that need careful management.

A new treatment using hydroxychloroquine, hyaluronidase, and steroids may improve hair loss from dermal filler complications.

5-alpha-reductase inhibitors lower PSA density but higher PSA density indicates disease progression.

Fibrosing alopecia in a pattern distribution is a hair loss condition often confused with other types, requiring early treatment but usually not resulting in significant hair regrowth.

A new method speeds up insulin amyloid fibril growth, useful for studying diseases.

A man's scalp condition was misidentified as hair loss dots but was actually a common follicular disorder.

Some postmenopausal women with frontal fibrosing alopecia stopped losing hair with finasteride treatment, hinting at a possible hormonal cause.

Arg1+ macrophages may play a role in Alopecia Areata, offering new treatment targets.

The conclusion is that it's important to tell apart alopecia areata from lipedematous alopecia for proper treatment, as alopecia areata can be reversed.